−0.013SGD
−9.62 MSGD
5.91 MSGD
414.32 M
About IX BIOPHARMA
Sector
CEO
Yip Hang Lee
Headquarters
Singapore
Website
Employees (FY)
68
Founded
2004
ISIN
SG1BD9000009
FIGI
BBG009LDQGX8
iX Biopharma Ltd. engages in the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. It operates through the Specialty Pharmaceutical and Nutraceutical segments. The Specialty Pharmaceutical segment develops, manufactures and sells pharmaceutical and nutraceutical products. The Nutraceutical segment offers nutraceutical products. The company was founded by Yip Hang Lee on May 8, 2004, and is headquartered in Singapore.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 42C is 0.040 SGD — it has decreased by 11.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SGX exchange IX BIOPHARMA stocks are traded under the ticker 42C.
IX BIOPHARMA is going to release the next earnings report on Aug 19, 2024. Keep track of upcoming events with our Earnings Calendar.
42C stock is 12.50% volatile and has beta coefficient of 0.00. Check out the list of the most volatile stocks — is IX BIOPHARMA there?
Yes, you can track IX BIOPHARMA financials in yearly and quarterly reports right on TradingView.
42C stock has fallen by 24.53% compared to the previous week, the month change is a 4.76% fall, over the last year IX BIOPHARMA has showed a 53.49% decrease.
42C net income for the last quarter is −7.33 M SGD, while the quarter before that showed −2.27 M SGD of net income which accounts for −223.43% change. Track more IX BIOPHARMA financial stats to get the full picture.
Today IX BIOPHARMA has the market capitalization of 30.73 M, it has increased by 4.00% over the last week.
No, 42C doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 42C shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IX BIOPHARMA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 68.00 employees. See our rating of the largest employees — is IX BIOPHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IX BIOPHARMA technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IX BIOPHARMA stock shows the sell signal. See more of IX BIOPHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IX BIOPHARMA EBITDA is −7.21 M SGD, and current EBITDA margin is −164.27%. See more stats in IX BIOPHARMA financial statements.